Key facts
- This page summarizes John W. Childs's Form 4 filing for Veradermics, Inc (MANE).
- 8 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 05 Feb 2026, 19:04.
John W. Childs - 03 Feb 2026 Form 4 Insider Report for Veradermics, Inc (MANE)
- Reporting relationship
- Director
- Issuer ticker
- MANE
- Reported as of
- 03 Feb 2026
- Net transaction value
- +$4,999,989
- SEC form
- 4
- Accepted by SEC
- 05 Feb 2026, 19:04:00 UTC
- Prior SEC filing
- 17 Nov 2025
- Next SEC filing
- 30 Apr 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael Greco, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John W. Childs filed Form 4 for Veradermics, Inc (MANE) on 05 Feb 2026.
Change
- Previous filing in this sequence was filed on 17 Nov 2025.
- Current net transaction value: +$4,999,989.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001027035
Primary reporting owner
CHILDS JOHN W
- Relationship
- Director
- Address
- C/O VERADERMICS, INCORPORATED, 470 JAMES ST., NEW HAVEN
- Signature
- /s/ Michael Greco, Attorney-in-Fact
- Signature date
- 05 Feb 2026
This filing has been restated.
Open the amended filing.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MANE
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +480,269
- Change %
- Price
- Shares after
- 480,269
- Date
- 05 Feb 2026
- Ownership
- See Footnote
- Footnotes
- F1, F2
MANE
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +906,862
- Change %
- +189%
- Price
- Shares after
- 1,387,131
- Date
- 05 Feb 2026
- Ownership
- See Footnote
- Footnotes
- F2, F3
MANE
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +520,758
- Change %
- +38%
- Price
- Shares after
- 1,907,889
- Date
- 05 Feb 2026
- Ownership
- See Footnote
- Footnotes
- F2, F4
MANE
transaction
Common Stock
Purchase
- Transaction value
- $4,999,989
- Shares
- +294,117
- Change %
- +15%
- Price
- $17.00
- Shares after
- 2,202,006
- Date
- 05 Feb 2026
- Ownership
- See Footnote
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MANE
transaction
Derivative
Series A Convertible Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -480,269
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 05 Feb 2026
- Ownership
- See Footnote
- Underlying class
- Common Stock
- Underlying amount
- 480,269
- Exercise price
- Footnotes
- F1, F2
MANE
transaction
Derivative
Series B Convertible Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -906,862
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 05 Feb 2026
- Ownership
- See Footnote
- Underlying class
- Common Stock
- Underlying amount
- 906,862
- Exercise price
- Footnotes
- F2, F3
MANE
transaction
Derivative
Series C Convertible Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -520,758
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 05 Feb 2026
- Ownership
- See Footnote
- Underlying class
- Common Stock
- Underlying amount
- 520,758
- Exercise price
- Footnotes
- F2, F4
MANE
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +51,525
- Change %
- Price
- $0.000000
- Shares after
- 51,525
- Date
- 03 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 51,525
- Exercise price
- $17.00
- Footnotes
- F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
On February 5, 2026, the shares of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share ("Common Stock"), on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date.
Footnote F2
Shares held by J.W. Childs Associates (FL), L.P. John W. Childs 2013 Revocable Trust is the sole owner of J.W. Childs Associates (FL), L.P. The Reporting Person, a member of the board of directors of the Issuer, is Trustee of John W. Childs 2013 Revocable Trust and may be deemed to hold voting and dispositive power with respect to these securities.
Footnote F3
On February 5, 2026, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date.
Footnote F4
On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date.
Footnote F5
This option shall be fully vested and exercisable on February 3, 2027, the first anniversary of the vesting commencement date.